Everything you need to make the right decisions
Providing the most comprehensive and up-to-date information and analysis of the Self Diagnostics market, and the behaviours, preferences and habits of the consumer.
Point of sale market data
In conjunction with IRi, extensive point of sale data shows you what consumers are spending their money on
How big is the market today and what is our 5 year forecast? Includes both best & worst case scenarios
What are the different segments within the market and how are those individual segments performing?
What are consumers looking for, what drives their buying habits and what are their main purchase influencers?
From iGen & Millennials to Baby Boomers & beyond. Who is spending money and what are they spending it on?
We gather our data from real-world consumers, selected to accurately reflect precise global demographics
What are the key players doing, what has been successful for them and what was their marketing spend?
Using data from our Global New Product Database, what products were launched and how well were they perceived?
What happens next, which areas are likely to experience growth and what opportunities exist within the market?
Mintel has the answers you’re looking for
What are the key challenges facing the industry and how fast are its rates of growth? Who is the consumer and what do they want? Where are the opportunities, where are the risks and what lies ahead?
The self diagnostics market is defined as any product, device, or
test which is used by the consumer, without medical or professional
assistance, to identify or monitor a specific health condition. This
includes chemically-based home testing kits or urine tests and
electronic devices, such as monitors or meters.
For the purpose of this report, Mintel has included the following in its
- blood glucose monitors
- blood pressure monitors
- lancet/devices and related testing accessories
- urine tests/kits
- other home testing kits
Excluded from this report are tests carried out by hospitals, doctors,
nurses, pharmacists or other healthcare workers. Tests performed
at home and developed by private laboratories are mentioned in the
report, with the retail test cost included in market size figures. Lab
processing figures are not included, as private labs are effectively
part of the medical community.
Also excluded are devices such as scales, which are used solely
to measure weight, and other physical measuring devices, such
as thermometers. Other tests and meters, which fit the definition of
self-diagnostics but are not included in the market size of this report,
but may be mentioned in the report, are those for:
- blood cholesterol
- body fat
- coagulation test kits
- cystic fibrosis
- dietary or vitamin deficiencies
- fecal test kits to identify bowel disorders
- genetics (including paternity tests)
- H. pylori
- male fertility testing
- peak flow meters to identify asthma and lung disorders
Expert analysis from a specialist in the field
Written by Marissa Gilbert, a leading analyst in the Health & Wellness sector, her extensive knowledge delivers in-depth commentary and analysis to highlight current trends and add expert context to the numbers.
The self diagnostics market is made up of several diverse segments all aiming to give consumers insight into their health. For the two largest segments, blood pressure and blood glucose monitoring, testing is likely to be done out of necessity and can be covered by insurance, which impacts retail sales. Among the smaller segments, there has been success in UTI (urinary tract infection) tests and drug testing kits. Private label products dominate as strong brand identities are lacking in most segments. The future of self diagnostics will be directed by the role of technology in tracking results and generating actionable data and the use of non-invasive devices in blood glucose testing.
Senior Health & Wellness Analyst